Rituximab and abatacept but not tocilizumab impair antibody response to pneumococcal conjugate vaccine in patients with rheumatoid arthritis

被引：0
|
作者：
Meliha Crnkic Kapetanovic
Tore Saxne
Göran Jönsson
Lennart Truedsson
Pierre Geborek
机构：
[1] Lund University,Department of Clinical Sciences Lund, Section of Rheumatology
[2] Lund University,Department of Clinical Sciences Lund, Section of Infectious Diseases
[3] Lund University,Department of Laboratory Medicine, Section of Microbiology, Immunology and Glycobiology
来源：
Arthritis Research & Therapy | / 15卷
关键词：
Rheumatoid Arthritis Patient; Tocilizumab; Abatacept; Invasive Pneumococcal Disease; Pneumococcal Conjugate Vaccine;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Antibody response to pneumococcal and influenza vaccination in patients with rheumatoid arthritis receiving abatacept
    Rieke Alten
    Clifton O. Bingham
    Stanley B. Cohen
    Jeffrey R. Curtis
    Sheila Kelly
    Dennis Wong
    Mark C. Genovese
    BMC Musculoskeletal Disorders, 17
  • [2] Antibody response to pneumococcal and influenza vaccination in patients with rheumatoid arthritis receiving abatacept
    Alten, Rieke
    Bingham, Clifton O., III
    Cohen, Stanley B.
    Curtis, Jeffrey R.
    Kelly, Sheila
    Wong, Dennis
    Genovese, Mark C.
    BMC MUSCULOSKELETAL DISORDERS, 2016, 17
  • [3] Rheumatoid factor as predictor of response to abatacept, rituximab and tocilizumab in rheumatoid arthritis: Systematic review and meta-analysis
    Maneiro, R. J.
    Salgado, Eva
    Carmona, Loreto
    Gomez-Reino, Juan J.
    SEMINARS IN ARTHRITIS AND RHEUMATISM, 2013, 43 (01) : 9 - 17
  • [4] Cancer risk with tocilizumab/sarilumab, abatacept and rituximab treatment in patients with rheumatoid arthritis: a Danish cohort study
    Westermann, Rasmus
    Cordtz, Rene Lindholm
    Duch, Kirsten
    Mellemkjaer, Lene
    Hetland, Merete Lund
    Magnussen, Bergur
    Dreyer, Lene
    RHEUMATOLOGY, 2024, : 1019 - 1028
  • [5] Impact of Janus kinase inhibitors on antibody response to 13-valent pneumococcal conjugate vaccine in patients with rheumatoid arthritis
    Mori, Shunsuke
    Ueki, Yukitaka
    Ishiwada, Naruhiko
    MODERN RHEUMATOLOGY, 2023, 33 (02) : 312 - 317
  • [6] Rituximab and abatacept in rheumatoid arthritis
    Gomez Centeno, Toni
    REUMATOLOGIA CLINICA, 2009, 5 : 77 - 81
  • [7] Risk of diverticulitis and gastrointestinal perforation in rheumatoid arthritis treated with tocilizumab compared to rituximab or abatacept
    Rempenault, Claire
    Lukas, Cedric
    Combe, Bernard
    Herrero, Astrid
    Pane, Isabelle
    Schaeverbeke, Thierry
    Wendling, Daniel
    Pham, Thao
    Gottenberg, Jacques-Eric
    Mariette, Xavier
    Morel, Jacques
    RHEUMATOLOGY, 2022, 61 (03) : 953 - 962
  • [8] Overall infection risk in rheumatoid arthritis during treatment with abatacept, rituximab and tocilizumab; an observational cohort study
    Gron, Kathrine L.
    Glintborg, Bente
    Norgaard, Mette
    Mehnert, Frank
    Ostergaard, Mikkel
    Dreyer, Lene
    Krogh, Niels S.
    Hetland, Merete L.
    RHEUMATOLOGY, 2020, 59 (08) : 1949 - 1956
  • [9] RITUXIMAB AND TOCILIZUMAB FOR THE TREATMENT OF RHEUMATOID ARTHRITIS
    Gonzalez-Vacarezza, Nicolas
    Aleman, Alicia
    Gonzalez, Graciela
    Perez, Ana
    INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2014, 30 (03) : 282 - 288
  • [10] Variability of rituximab and tocilizumab trough concentrations in patients with rheumatoid arthritis
    Truffot, Aurelie
    Gautier-Veyret, Elodie
    Baillet, Athan
    Jourdil, Jean-Francois
    Stanke-Labesque, Francoise
    Gottenberg, Jacques-Eric
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2021, 35 (06) : 1090 - 1099
12345